Literature DB >> 6891236

Isosorbide dinitrate pharmacokinetics.

T Taylor, L F Chasseaud, E Doyle, R Bonn, A Darragh, R F Lambe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6891236

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN： 0004-4172


× No keyword cloud information.
  9 in total

1.  The effect of food on the oral absorption of isosorbide-5-mononitrate.

Authors:  H Laufen; M Leitold
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

2.  Pharmacokinetics of isosorbide dinitrate and its mononitrate metabolites after intravenous infusion.

Authors:  Y Santoni; A Iliadis; J P Cano; R Luccioni; Y Frances
Journal:  J Pharmacokinet Biopharm       Date:  1986-02

Review 3.  Clinical pharmacokinetics of organic nitrates.

Authors:  M G Bogaert
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

4.  Concentrations of isosorbide dinitrate, isosorbide-2-mononitrate and isosorbide-5-mononitrate in human vascular and muscle tissue under steady-state conditions.

Authors:  W Schneider; G Menke; R Heidemann; P Satter; M Kaltenbach; N Rietbrock
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration.

Authors:  U Abshagen; G Betzien; R Endele; B Kaufmann; G Neugebauer
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  The effects of bupivacaine injection and oral nitric oxide on extraocular muscle in the rabbit.

Authors:  Burak Bilgin; Huseyin Gursoy; Hikmet Basmak; Mete Ozkurt; Nese Tuncel; Funda Canaz; Serap Isiksoy; Ertugrul Colak
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-06-04       Impact factor: 3.117

7.  Isosorbide dinitrate in plasma and dialysate during haemodialysis.

Authors:  H Bauer; H Laufen; H E Franz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Pharmacokinetics and haemodynamic effects of ISDN following different dosage forms and routes of administration.

Authors:  D Vogt; D Trenk; R Bonn; E Jähnchen
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 9.  Clinical pharmacokinetics of vasodilators. Part II.

Authors:  R Kirsten; K Nelson; D Kirsten; B Heintz
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.